Zobrazeno 1 - 10
of 499
pro vyhledávání: '"U, Bartz"'
Publikováno v:
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background This study aimed to investigate the incidence of and risk factors for the anterior chamber migration of an intravitreal dexamethasone implant (Ozurdex®). Methods A retrospective review of 640 consecutive intravitreal dexamethason
Externí odkaz:
https://doaj.org/article/6d023308172f4585898e1ad434bd7054
Autor:
S. Schnichels, M. Blak, J. Hurst, T. Dorfi, K. U. Bartz-Schmidt, F. Ziemssen, M. S. Spitzer, M. Schultheiss
Publikováno v:
Biology Open, Vol 6, Iss 7, Pp 1056-1064 (2017)
Hypoxia plays an important role in several retinal diseases, especially in central retinal artery occlusion (CRAO). Although CRAO has been known for over a hundred years, no cure or sufficient treatment is available. Potential therapies are being eva
Externí odkaz:
https://doaj.org/article/f8f571d01c834ee7b95e94e2d240f3d3
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198793 (2018)
PURPOSE:This study aimed to investigate the trends in the surgical methods and leading indications for corneal transplantations carried out over the last 12 years. METHODS:The data from the corneal graft waiting list and from all keratoplasties carri
Externí odkaz:
https://doaj.org/article/7d9206801e13456cb2b3d41d01315ec6
Autor:
Maximilian Schultheiss, Florian Härtig, Martin S Spitzer, Nicolas Feltgen, Bernhard Spitzer, Johannes Hüsing, André Rupp, Ulf Ziemann, Karl U Bartz-Schmidt, Sven Poli
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0198114 (2018)
BACKGROUND:No evidence-based therapy exists for non-arteritic central retinal artery occlusion (NA-CRAO). Retinal ischemic tolerance is low; irreversible damage occurs within four hours of experimental NA-CRAO. In previous randomized trials evaluatin
Externí odkaz:
https://doaj.org/article/acaf8664c573482aa156f9670bf345a8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katarina Stingl, Ruth Schippert, Karl U. Bartz-Schmidt, Dorothea Besch, Charles L. Cottriall, Thomas L. Edwards, Florian Gekeler, Udo Greppmaier, Katja Kiel, Assen Koitschev, Laura Kühlewein, Robert E. MacLaren, James D. Ramsden, Johann Roider, Albrecht Rothermel, Helmut Sachs, Greta S. Schröder, Jan Tode, Nicole Troelenberg, Eberhart Zrenner
Publikováno v:
Frontiers in Neuroscience, Vol 11 (2017)
Purpose: We assessed the safety and efficacy of a technically advanced subretinal electronic implant, RETINA IMPLANT Alpha AMS, in end stage retinal degeneration in an interim analysis of two ongoing prospective clinical trials. The purpose of this a
Externí odkaz:
https://doaj.org/article/a36b08621b894d71b1d1c498ff334af9
Autor:
Kristina Spaniol, Martin Hellmich, Klara Borgardts, Christian Girbardt, Philip Maier, Thomas Reinhard, Necip Torun, Anna‐Karina Maier, Sebastian Thaler, Karl U. Bartz‐Schmidt, Peter Wiedemann, Berthold Seitz, Loay Daas, Silvia Schrittenlocher, Claus Cursiefen, Björn Bachmann, Gerd Geerling
Publikováno v:
Acta Ophthalmologica. 101
Descemet membrane endothelial keratoplasty (DMEK) accounts for50% of all corneal transplants in Germany. So far, no data from such a large multicenter study have been published.This retrospective study included 3200 DMEKs at seven departments perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dccac5725388107b1af5acd0b715e85
https://doi.org/10.1111/aos.15257
https://doi.org/10.1111/aos.15257
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fabian Wozar, Krunoslav Stingl, Ronja Jung, Friederike Kortüm, Bernd Wissinger, Eberhart Zrenner, Felix F L Reichel, Tobias Peters, Fadi Nasser, Carina Kelbsch, Karl U. Bartz-Schmidt, Katarina Stingl, Barbara Wilhelm, Spyridon Dimopoulos, Susanne Kohl, M. Dominik Fischer, Melanie Kempf
Publikováno v:
British Journal of Ophthalmology. 106:831-838
BackgroundVoretigene neparvovec is a gene therapeutic agent for treatment of retinal dystrophies caused by bi-allelic RPE65 mutations. In this study, we report on a novel and objective evaluation of a retinotopic photoreceptor rescue.MethodsSeven eye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04fc42f5466df043f5165cdc27cfdb8
https://doi.org/10.1136/bjophthalmol-2020-318286
https://doi.org/10.1136/bjophthalmol-2020-318286
Autor:
Maximilian Schultheiss, Sven Schnichels, Thoralf Hermann, Jose Hurst, Marita Feldkaemper, Blanca Arango-Gonzalez, Marius Ueffing, Karl U Bartz-Schmidt, Guenther Zeck, Martin S Spitzer
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148616 (2016)
PURPOSE:Hypothermia has been shown to be neuroprotective in the therapy of ischemic stroke in the brain. To date no studies exist on the level of the inner retina and it is unclear if hypothermia would prolong the ischemic tolerance time of retinal g
Externí odkaz:
https://doaj.org/article/1795f08bcbcc4b19bb87f6b05816eca3